Reprogramming tumor microenvironment via systemic delivery of TLR3 agonist and manganese nanoparticle.
Ontology highlight
ABSTRACT: Toll-like receptor (TLR) agonists, as potent immunostimulatory adjuvants, play a critical role in linking the innate and adaptive immune responses. However, their antitumor effects as cancer immunotherapeutic agents have been limited. Here, we report our finding that manganese ion (Mn2+) potentiates various TLR agonists, leading to robust activation of the TLR pathway and the stimulator of interferon genes (STING) pathway among innate immune cells. In particular, we have observed robust antitumor efficacy after intratumoral administration of a TLR3 agonist and Mn2+. To achieve systemic codelivery of TLR3 agonist and Mn2+, we have developed a low-molecular-weight poly(inosinic:cytidylic acid)-Mn2+ coordination lipid nanoparticle (PLCMP). When admi
SUBMITTER: Cho YS
PROVIDER: S-EPMC12626007 | biostudies-literature | 2025 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA